BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q2 EPS of ($0.59), $0.41 better than the analyst estimate of ($1.00).

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.